An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition: HypertensionInterventions: Drug: Aliskiren; Drug: EnalaprilSponsor: Novartis PharmaceuticalsRecruiting - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials